# Italian Non-Interventional Study of FLT3 Mutated AML Patients

> **NCT03547258** · — · UNKNOWN · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 800 (estimated)

## Conditions studied

- AML
- FLT3-ITD Mutation
- FLT3-TKD Mutation

## Interventions

- **GENETIC:** Clinical and Molecular data collection

## Key facts

- **NCT ID:** NCT03547258
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-18
- **Primary completion:** 2021-05
- **Final completion:** 2021-05
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03547258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03547258, "Italian Non-Interventional Study of FLT3 Mutated AML Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03547258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*